Evolving management of symptomatic chronic subdural hematoma: Experience of a single institution and review of the literature

David Balser, Shaun D. Rodgers, Blair Johnson, Chen Shi, Esteban Tabak, Uzma Samadani

Research output: Contribution to journalArticle

Abstract

Objective: Chronic subdural hematoma (cSDH) has an increasing incidence and results in high morbidity and mortality. We review here the 10-year experience of a single institution and the literature regarding the treatment and major associations of cSDH. Methods: We retrospectively reviewed all cSDHs surgically treated from 2000 to 2010 in the New York Harbor Health Care System to evaluate the duration from admission to treatment, type of treatment, length of stay (LOS) in critical care, LOS in the hospital, and recurrence. The literature was reviewed with regards to incidence, associations, and treatment of cSDH. Results: From 2000 to 2008, 44 patients were treated with burr holes (BHs). From 2008 to 2010, 29 patients were treated with twist-drill evacuation (subdural evacuating port system, SEPS). Four patients from each group were readmitted for reoperation (9% vs 14%; P 5 0.53). The average time to intervention for SEPS (11.2±15.3 hours) was faster than for BHs (40.3±69.1 hours) (P 5 0.02). The total hospital LOS was shorter for SEPS (9.3±6.8 days) versus BHs (13.4±10.2 days) (P 5 0.04); both were significantly longer than for a brain tumor patient undergoing craniotomy (7.0±0.5 days, n 5 94, P, 0.01). Conclusion: Despite decreasing LOSs as treatment for cSDH evolved from BHs to SEPS, the LOS for a cSDH is still longer than that of a patient undergoing craniotomy for brain tumor. We noted 11% recurrence in our series of patients, which included individuals who recurred as late as 3 years after initial diagnosis.

Original languageEnglish (US)
Pages (from-to)233-242
Number of pages10
JournalNeurological Research
Volume35
Issue number3
DOIs
StatePublished - 2013

Fingerprint

Hematoma, Subdural, Chronic
Length of Stay
Craniotomy
Brain Neoplasms
Therapeutics
Recurrence
Mandrillus
Incidence
Critical Care
Reoperation
Morbidity
Delivery of Health Care
Mortality

Keywords

  • Burr hole
  • Cerebral atrophy
  • Cost
  • Incidence
  • SEPS
  • Subdural hematoma

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Evolving management of symptomatic chronic subdural hematoma : Experience of a single institution and review of the literature. / Balser, David; Rodgers, Shaun D.; Johnson, Blair; Shi, Chen; Tabak, Esteban; Samadani, Uzma.

In: Neurological Research, Vol. 35, No. 3, 2013, p. 233-242.

Research output: Contribution to journalArticle

Balser, David ; Rodgers, Shaun D. ; Johnson, Blair ; Shi, Chen ; Tabak, Esteban ; Samadani, Uzma. / Evolving management of symptomatic chronic subdural hematoma : Experience of a single institution and review of the literature. In: Neurological Research. 2013 ; Vol. 35, No. 3. pp. 233-242.
@article{62734421337e4a63915a6b7d099144af,
title = "Evolving management of symptomatic chronic subdural hematoma: Experience of a single institution and review of the literature",
abstract = "Objective: Chronic subdural hematoma (cSDH) has an increasing incidence and results in high morbidity and mortality. We review here the 10-year experience of a single institution and the literature regarding the treatment and major associations of cSDH. Methods: We retrospectively reviewed all cSDHs surgically treated from 2000 to 2010 in the New York Harbor Health Care System to evaluate the duration from admission to treatment, type of treatment, length of stay (LOS) in critical care, LOS in the hospital, and recurrence. The literature was reviewed with regards to incidence, associations, and treatment of cSDH. Results: From 2000 to 2008, 44 patients were treated with burr holes (BHs). From 2008 to 2010, 29 patients were treated with twist-drill evacuation (subdural evacuating port system, SEPS). Four patients from each group were readmitted for reoperation (9{\%} vs 14{\%}; P 5 0.53). The average time to intervention for SEPS (11.2±15.3 hours) was faster than for BHs (40.3±69.1 hours) (P 5 0.02). The total hospital LOS was shorter for SEPS (9.3±6.8 days) versus BHs (13.4±10.2 days) (P 5 0.04); both were significantly longer than for a brain tumor patient undergoing craniotomy (7.0±0.5 days, n 5 94, P, 0.01). Conclusion: Despite decreasing LOSs as treatment for cSDH evolved from BHs to SEPS, the LOS for a cSDH is still longer than that of a patient undergoing craniotomy for brain tumor. We noted 11{\%} recurrence in our series of patients, which included individuals who recurred as late as 3 years after initial diagnosis.",
keywords = "Burr hole, Cerebral atrophy, Cost, Incidence, SEPS, Subdural hematoma",
author = "David Balser and Rodgers, {Shaun D.} and Blair Johnson and Chen Shi and Esteban Tabak and Uzma Samadani",
year = "2013",
doi = "10.1179/1743132813Y.0000000166",
language = "English (US)",
volume = "35",
pages = "233--242",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "3",

}

TY - JOUR

T1 - Evolving management of symptomatic chronic subdural hematoma

T2 - Experience of a single institution and review of the literature

AU - Balser, David

AU - Rodgers, Shaun D.

AU - Johnson, Blair

AU - Shi, Chen

AU - Tabak, Esteban

AU - Samadani, Uzma

PY - 2013

Y1 - 2013

N2 - Objective: Chronic subdural hematoma (cSDH) has an increasing incidence and results in high morbidity and mortality. We review here the 10-year experience of a single institution and the literature regarding the treatment and major associations of cSDH. Methods: We retrospectively reviewed all cSDHs surgically treated from 2000 to 2010 in the New York Harbor Health Care System to evaluate the duration from admission to treatment, type of treatment, length of stay (LOS) in critical care, LOS in the hospital, and recurrence. The literature was reviewed with regards to incidence, associations, and treatment of cSDH. Results: From 2000 to 2008, 44 patients were treated with burr holes (BHs). From 2008 to 2010, 29 patients were treated with twist-drill evacuation (subdural evacuating port system, SEPS). Four patients from each group were readmitted for reoperation (9% vs 14%; P 5 0.53). The average time to intervention for SEPS (11.2±15.3 hours) was faster than for BHs (40.3±69.1 hours) (P 5 0.02). The total hospital LOS was shorter for SEPS (9.3±6.8 days) versus BHs (13.4±10.2 days) (P 5 0.04); both were significantly longer than for a brain tumor patient undergoing craniotomy (7.0±0.5 days, n 5 94, P, 0.01). Conclusion: Despite decreasing LOSs as treatment for cSDH evolved from BHs to SEPS, the LOS for a cSDH is still longer than that of a patient undergoing craniotomy for brain tumor. We noted 11% recurrence in our series of patients, which included individuals who recurred as late as 3 years after initial diagnosis.

AB - Objective: Chronic subdural hematoma (cSDH) has an increasing incidence and results in high morbidity and mortality. We review here the 10-year experience of a single institution and the literature regarding the treatment and major associations of cSDH. Methods: We retrospectively reviewed all cSDHs surgically treated from 2000 to 2010 in the New York Harbor Health Care System to evaluate the duration from admission to treatment, type of treatment, length of stay (LOS) in critical care, LOS in the hospital, and recurrence. The literature was reviewed with regards to incidence, associations, and treatment of cSDH. Results: From 2000 to 2008, 44 patients were treated with burr holes (BHs). From 2008 to 2010, 29 patients were treated with twist-drill evacuation (subdural evacuating port system, SEPS). Four patients from each group were readmitted for reoperation (9% vs 14%; P 5 0.53). The average time to intervention for SEPS (11.2±15.3 hours) was faster than for BHs (40.3±69.1 hours) (P 5 0.02). The total hospital LOS was shorter for SEPS (9.3±6.8 days) versus BHs (13.4±10.2 days) (P 5 0.04); both were significantly longer than for a brain tumor patient undergoing craniotomy (7.0±0.5 days, n 5 94, P, 0.01). Conclusion: Despite decreasing LOSs as treatment for cSDH evolved from BHs to SEPS, the LOS for a cSDH is still longer than that of a patient undergoing craniotomy for brain tumor. We noted 11% recurrence in our series of patients, which included individuals who recurred as late as 3 years after initial diagnosis.

KW - Burr hole

KW - Cerebral atrophy

KW - Cost

KW - Incidence

KW - SEPS

KW - Subdural hematoma

UR - http://www.scopus.com/inward/record.url?scp=84875179268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875179268&partnerID=8YFLogxK

U2 - 10.1179/1743132813Y.0000000166

DO - 10.1179/1743132813Y.0000000166

M3 - Article

VL - 35

SP - 233

EP - 242

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 3

ER -